Cefazolin and Phoslo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefazolin (cefazolin sodium) and Phoslo (calcium acetate). Common drug interactions include injury among females and depression among males.

The phase IV clinical study analyzes what interactions people have when they take Cefazolin and Phoslo. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Cefazolin?

Cefazolin has active ingredients of cefazolin sodium. It is often used in infection. eHealthMe is studying from 15,157 Cefazolin users. Check the latest studies of Cefazolin.

What is Phoslo?

Phoslo has active ingredients of calcium acetate. eHealthMe is studying from 4,291 Phoslo users. Check the latest studies of Phoslo.

On Jul, 14, 2026

23 people who take Cefazolin and Phoslo together, and have interactions are studied.

What are the common drug interactions of Cefazolin and Phoslo, by gender? *:

female:

Injury
Normochromic normocytic anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits)
Pain
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Renal injury (kidney injury)
Scotoma (an area of diminished vision within the visual field)
Stress
Thyroid neoplasm (tumour of thyroid)
Vasculitis (inflammation of a blood vessel or blood vessels)

male:

Depression
Erythema (redness of the skin)
Renal failure (kidney dysfunction)
Abdominal pain
Anuria (failure of the kidneys to produce urine)
Asthenia (weakness)
Chest pain
Colitis (inflammation of colon)
Confusional state
Contusion (a type of hematoma of tissue in which capillaries)

What are the common drug interactions of Cefazolin and Phoslo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Bone marrow failure
Normochromic normocytic anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits)
Scotoma (an area of diminished vision within the visual field)
Thyroid neoplasm (tumour of thyroid)
Vasculitis (inflammation of a blood vessel or blood vessels)

30-39:

Arrhythmia (irregular heartbeat)
Cardiac failure
Chronic kidney disease
Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Pruritus (severe itching of the skin)
Renal failure (kidney dysfunction)
Skin exfoliation (removal of the oldest dead skin cells)

40-49:

n/a

50-59:

Cough
Cytomegalovirus test positive
Dysphagia (a condition in which swallowing is difficult or painful)
Fall
Feeding disorder (when children refuse to eat certain food groups)
Haematuria (presence of blood in urine)
Hyperkalaemia (damage to or disease of the kidney)
Hypertension (high blood pressure)
Insomnia (sleeplessness)
Kidney transplant rejection

60+:

Abdominal pain
Anuria (failure of the kidneys to produce urine)
Diarrhoea
Dizziness
Dysphagia (a condition in which swallowing is difficult or painful)
Electrolyte imbalance
Erythema (redness of the skin)
Excoriation (to tear or wear off the skin of)
Eye movement disorder
Failure to thrive (inadequate weight gain and physical growth in children)

What are the existing conditions these people have? *

Urinary Incontinence (inability to control the flow of urine and involuntary urination): 5 people, 21.74%
Enlarged Prostate: 5 people, 21.74%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 13.04%
Nuclear Magnetic Resonance Imaging Abdominal: 2 people, 8.70%
High Blood Pressure: 2 people, 8.70%
High Blood Cholesterol: 2 people, 8.70%
Fever: 2 people, 8.70%
Chronic Renal Failure (kidney failure): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Cefazolin and Phoslo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously